AI assistant
Sending…
ORTHOPEDIATRICS CORP — Director's Dealing 2017
Oct 16, 2017
32906_dirs_2017-10-16_a748bdd7-8df9-48c4-9150-f0a1e95e3301.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2017-10-16
Reporting Person: Berry Bernie B III (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-16 | Common Stock | C | 4020 | — | Acquired | 38263 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-16 | Series B Convertible Preferred Stock | $ | C | 6000 | Disposed | Common Stock (4020) | Direct |
Footnotes
F1: Represents shares received upon conversion of the Series B Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering.
F2: Each share of Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.
More from ORTHOPEDIATRICS CORP
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 20
Capital/Financing Update
2026
Apr 1
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17